NBR Lister Guy Haddleton is stepping back from the role of Helius Therapeutics chair, appointing Candace Kinser to the position, but he will stay on the board.
Haddleton and wife Sue control 88.3% of the medical cannabis company and he had served as chair since investing $15 million in the
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
